Summit Therapeutics has seen sharp swings in sentiment after mixed regulatory news around its lead cancer drug, which puts a fresh spotlight on whether the current share price lines up with the value ...
Source LinkSummit Therapeutics has seen sharp swings in sentiment after mixed regulatory news around its lead cancer drug, which puts a fresh spotlight on whether the current share price lines up with the value ...
Source Link
Comments